VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

MDS 2020 | Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS

Susanne Schneider, MD, PhD, University Hospital Munich, Munich, Germany, discusses the treatment options for dystonia including oral anticholinergics, levodopa for dopamine responsive dystonia, botulinum toxin and surgical options such as deep brain stimulation (DBS). Prof. Schneider also discusses the similar developments in Parkinson’s disease, specifically in lysosomal storage disorders. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).